Related Experiment Video

Updated: Oct 9, 2025

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
09:21

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Published on: January 18, 2018

12.2K

Outcomes after reperfusion therapies in patients with ACA stroke: A multicenter cohort study from the EVATRISP

A Filioglo1, N Simaan1, A Honig1

  • 1Departments of Neurology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.

Journal of the Neurological Sciences
|December 17, 2021
PubMed

Insights

For anterior cerebral artery strokes, endovascular thrombectomy (EVT) and intravenous thrombolysis (IVT) show similar safety and effectiveness. Treatment outcomes were not affected by clot location within the anterior cerebral artery (ACA).

Area of Science:

  • Neurology
  • Vascular Neurology
  • Interventional Neurology

Background:

  • Anterior cerebral artery (ACA) strokes often lead to poor patient outcomes.
  • The optimal acute treatment for ACA occlusive strokes remains uncertain.

Purpose of the Study:

  • To compare the effectiveness and safety of endovascular thrombectomy (EVT) versus intravenous thrombolysis (IVT) for acute anterior cerebral artery (ACA) strokes.

Main Methods:

  • Retrospective analysis of 92 patients with isolated ACA stroke from the EVATRISP registry.
  • Comparison of outcomes between patients treated with EVT and those treated with IVT using multivariate regression analysis.

Main Results:

  • No significant differences in favorable outcome, mortality, or symptomatic intracranial hemorrhage between EVT and IVT groups.
  • EVT patients more frequently presented with wake-up strokes and proximal occlusions.
  • Clot location within the ACA (A1 vs. A2/A3 segments) did not influence treatment outcomes.

Conclusions:

  • Both IVT and EVT appear to be safe and similarly effective treatments for ACA strokes.
  • Treatment efficacy for ACA strokes may be independent of the specific clot location within the artery.
Abstract

Keywords:
Anterior cerebral arteryCerebrovascular diseaseEndovascularStrokeThrombectomy

More Related Videos

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction05:26

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction

Published on: May 28, 2019

9.4K
Optimization of the Longa Middle Cerebral Artery Occlusion Method for Complete Reperfusion13:18

Optimization of the Longa Middle Cerebral Artery Occlusion Method for Complete Reperfusion

Published on: November 22, 2024

1.3K

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
40
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
47
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
76
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
46
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
108
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
62